Longboat

Advarra Hires Clinical Research Industry Veteran Christine Senn to Bring Sites and Sponsors Together, Driving Speed Not Siloes

Retrieved on: 
Tuesday, March 5, 2024

COLUMBIA, Md., March 5, 2024 /PRNewswire/ -- Advarra, the market leader in regulatory review solutions and clinical research technology for sites and sponsors, welcomes clinical industry veteran Christine Senn, PhD, as Senior Vice President, Head of Site-Sponsor Innovation. With extensive site leadership experience and a longstanding personal goal to drive site-sponsor collaboration, Senn will lead Advarra's effort to remove barriers between stakeholders and connect a siloed clinical research ecosystem – ultimately, to accelerate clinical trials.

Key Points: 
  • COLUMBIA, Md., March 5, 2024 /PRNewswire/ -- Advarra , the market leader in regulatory review solutions and clinical research technology for sites and sponsors, welcomes clinical industry veteran Christine Senn , PhD, as Senior Vice President, Head of Site-Sponsor Innovation.
  • She will also drive and oversee the development of innovative ways to bring clinical trial sites and sponsors together in support of Advarra's mission.
  • "Fostering collaboration of all clinical research stakeholders has been important to me throughout my career," said Christine Senn.
  • Onsemble is the industry's largest gathering of clinical research site professionals, including cancer centers, children's hospitals, research consortia, academic medical centers, healthcare systems, and more.

Advarra to Bring True Single Sign-On Capabilities to Clinical Trial Sites, Increasing Efficiency and Improving Security

Retrieved on: 
Monday, February 12, 2024

COLUMBIA, Md., Feb. 12, 2024 /PRNewswire/ -- Advarra, the market leader in regulatory review solutions and clinical research technology for sites and sponsors, announces single sign-on technology for clinical trial sites to reduce friction, increase security and free time to focus on patients. Advarra's new single sign-on (SSO) capabilities empower site staff to use their own site-sanctioned credentials to access key systems including sponsor-provided technology. An industry-first, Advarra SSO delivers a sought-after process simplification crucial to sites, especially as the number of trial technologies continues to grow.

Key Points: 
  • Advarra's new single sign-on (SSO) capabilities empower site staff to use their own site-sanctioned credentials to access key systems including sponsor-provided technology.
  • An industry-first, Advarra SSO delivers a sought-after process simplification crucial to sites, especially as the number of trial technologies continues to grow.
  • Advarra SSO capability is already available for Advarra site technology, and will be available within Advarra Longboat in early 2024.
  • • Learn more about Advarra's site-specific clinical trial technology: www.advarra.com/solutions-for/clinical-trial-sites/
    • Connect with Advarra on LinkedIn: linkedin.com/company/advarra

Advarra Launches Next-Generation Technology to Align Patients, Sites, and Sponsors in Clinical Trials

Retrieved on: 
Wednesday, October 4, 2023

COLUMBIA, Md., Oct. 4, 2023 /PRNewswire/ -- Advarra, the market leader in regulatory review solutions and clinical research technology for sites and sponsors, announces new technology functionality designed to improve all stakeholders' clinical trial experiences. Longboat, an established platform used in more than 70 countries and by nearly 20,000 sites, now features an online patient portal with a comprehensive set of engagement tools including a simple document exchange that enables transparent collaboration between patients, sites, and sponsors or clinical research organizations (CROs) without adding technology burden.

Key Points: 
  • COLUMBIA, Md., Oct. 4, 2023 /PRNewswire/ -- Advarra, the market leader in regulatory review solutions and clinical research technology for sites and sponsors, announces new technology functionality designed to improve all stakeholders' clinical trial experiences.
  • Advarra launches new technology to align patients, sites, and sponsors in clinical trials.
  • A common complaint of trial participants is the lack of access to their individual clinical trial data and documents.
  • At the same time, clinical trial sites are overburdened, using 20 or more systems daily to manage a trial.

Award-winning Florida Realtor Yvette Sellyn Launches New Website Dedicated to Luxury Living

Retrieved on: 
Tuesday, September 6, 2022

Browse my new website and take a look at luxury living the Sarasota way https://yvettesellyn.com/.

Key Points: 
  • Browse my new website and take a look at luxury living the Sarasota way https://yvettesellyn.com/.
  • Yvette Sellyn is the perfect match for homeowners looking for a personalised approach to selling, or motivated buyers on the hunt for their forever Florida home.
  • Yvette is a knowledgeable and skilled Realtor, with local expertise specializing in luxury properties.
  • Yvette Sellyn over 25 years experience in business, negotiations and making good connections!